Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|June 23, 2006
New 2',6'-dimethyl-L-tyrosine (Dmt) opioid peptidomimetics based on the Aba-Gly scaffold. Development of unique mu-opioid receptor ligandsSteven Ballet, Severo Salvadori, Claudio Trapella, et al.
European Journal of Medicinal Chemistry|January 11, 2011
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-TicGianfranco Balboni, Severo Salvadori, Ewa D Marczak, et al.
Antiviral Chemistry & Chemotherapy|October 31, 2015
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivativesNorikazu Sakakibara, Gianfranco Balboni, Cenzo Congiu, et al.
Neuropharmacology|December 20, 2016
Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's diseaseSilvia Caioli, Cinzia Severini, Teresa Ciotti, et al.
Molecular Pharmacology|November 24, 2012
Conformational dynamics of Kir3.1/Kir3.2 channel activation via δ-opioid receptorsMelissa Richard-Lalonde, Karim Nagi, Nicolas Audet, et al.
Peptides|September 12, 2006
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studiesRaffaella Vergura, Elena Valenti, Christopher P Hebbes, et al.
Peptides|December 11, 2007
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonistRaffaella Vergura, Gianfranco Balboni, Barbara Spagnolo, et al.
Biomedicines|April 3, 2021
Evidence-Based View of Safety and Effectiveness of Prokineticin Receptors Antagonists during PregnancyDeborah Reynaud, Frederic Sergent, Roland Abi Nahed, et al.
Bioorganic & Medicinal Chemistry|March 7, 2007
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophoreGianfranco Balboni, Valentina Onnis, Cenzo Congiu, et al.
Neuropharmacology|August 14, 2019
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin systemDaniela Maftei, Patrizia Ratano, Ilaria Fusco, et al.
Pageof 10